These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 20673554)

  • 21. Efficacy and Safety of Adding Lurasidone to Ongoing Therapy With Lithium or Valproate for the Treatment of an Acute Bipolar Depressive Episode: A Post Hoc Analysis of 2 Placebo-Controlled Trials.
    Tocco M; Mao Y
    J Clin Psychopharmacol; 2024 Jul-Aug 01; 44(4):345-352. PubMed ID: 38639433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
    Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: a double-blind, randomized, placebo-controlled trial.
    Muzina DJ; Gao K; Kemp DE; Khalife S; Ganocy SJ; Chan PK; Serrano MB; Conroy CM; Calabrese JR
    J Clin Psychiatry; 2011 Jun; 72(6):813-9. PubMed ID: 20816041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
    Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M;
    J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study.
    DeBattista C; Doghramji K; Menza MA; Rosenthal MH; Fieve RR;
    J Clin Psychiatry; 2003 Sep; 64(9):1057-64. PubMed ID: 14628981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study.
    Wang Z; Gao K; Kemp DE; Chan PK; Serrano MB; Conroy C; Fang Y; Ganocy SJ; Findling RL; Calabrese JR
    Psychopharmacol Bull; 2010; 43(4):5-21. PubMed ID: 21240149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder.
    Durgam S; Earley W; Guo H; Li D; Németh G; Laszlovszky I; Fava M; Montgomery SA
    J Clin Psychiatry; 2016 Mar; 77(3):371-8. PubMed ID: 27046309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials.
    Rajagopalan K; Bacci ED; Ng-Mak D; Wyrwich K; Pikalov A; Loebel A
    BMC Psychiatry; 2016 May; 16():157. PubMed ID: 27215976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjunctive lumateperone (ITI-007) in the treatment of bipolar depression: Results from a randomized placebo-controlled clinical trial.
    Suppes T; Durgam S; Kozauer SG; Chen R; Lakkis HD; Davis RE; Satlin A; Vanover KE; Mates S; McIntyre RS; Tohen M
    Bipolar Disord; 2023 Sep; 25(6):478-488. PubMed ID: 36779257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
    McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH;
    J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex.
    Houston JP; Ahl J; Meyers AL; Kaiser CJ; Tohen M; Baldessarini RJ
    J Clin Psychiatry; 2006 Aug; 67(8):1246-52. PubMed ID: 16965203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression.
    Frye MA; Grunze H; Suppes T; McElroy SL; Keck PE; Walden J; Leverich GS; Altshuler LL; Nakelsky S; Hwang S; Mintz J; Post RM
    Am J Psychiatry; 2007 Aug; 164(8):1242-9. PubMed ID: 17671288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The antidepressant effects of risperidone and olanzapine in bipolar disorder.
    McIntyre RS; Mancini DA; Srinivasan J; McCann S; Konarski JZ; Kennedy SH
    Can J Clin Pharmacol; 2004; 11(2):e218-26. PubMed ID: 15520475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levetiracetam in the management of bipolar depression: a randomized, double-blind, placebo-controlled trial.
    Saricicek A; Maloney K; Muralidharan A; Ruf B; Blumberg HP; Sanacora G; Lorberg B; Pittman B; Bhagwagar Z
    J Clin Psychiatry; 2011 Jun; 72(6):744-50. PubMed ID: 21034692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension.
    Szegedi A; Calabrese JR; Stet L; Mackle M; Zhao J; Panagides J;
    J Clin Psychopharmacol; 2012 Feb; 32(1):46-55. PubMed ID: 22198448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania.
    Machado-Vieira R; Soares JC; Lara DR; Luckenbaugh DA; Busnello JV; Marca G; Cunha A; Souza DO; Zarate CA; Kapczinski F
    J Clin Psychiatry; 2008 Aug; 69(8):1237-45. PubMed ID: 18681754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
    Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.
    Berman RM; Marcus RN; Swanink R; McQuade RD; Carson WH; Corey-Lisle PK; Khan A
    J Clin Psychiatry; 2007 Jun; 68(6):843-53. PubMed ID: 17592907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: randomised double-blind placebo-controlled trial.
    Yatham LN; Vieta E; Goodwin GM; Bourin M; de Bodinat C; Laredo J; Calabrese J;
    Br J Psychiatry; 2016 Jan; 208(1):78-86. PubMed ID: 25999335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.